Results 171 to 180 of about 9,263,948 (394)

Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Efficacy and safety of ibrutinib 560 mg once daily or placebo combined with bendamustine and rituximab (BR) were assessed in patients with mantle cell lymphoma in a randomized phase 3 study (SHINE). The analysis described explores the ibrutinib population pharmacokinetics (PK) and exposure‐response (E‐R) relationships of selected efficacy and ...
Per Olsson Gisleskog, Belén Valenzuela, Nicoline Treijtel, Sanjay Deshpande, Todd Henninger, Juan José Perez‐Ruixo   +5 more
wiley   +1 more source

Idiopathic Thrombocytopenia Purpura Masking Hodgkin Disease: A Paraneoplastic Syndrome or Simply a Mere Association? [PDF]

Case Rep Oncol, 2017
Poponea N, Suede M, Muhsin Chisti M.
europepmc   +1 more source

Hodgkins disease [PDF]

British Journal of Cancer, 2001
C, Ferme, J M, Cosset, B, Fervers, C, Sebban, B, Cutuli, M, Henry-Amar, J, Stines, F, Giammarile, P, Bey, A M, Carella, T, Philip   +10 more
openaire   +2 more sources

Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions [PDF]

, 2001
Ralf Küppers, Andreas Bräuninger, Markus Müschen, Verena Distler, Martin‐Leo Hansmann, Klaus Rajewsky   +5 more
openalex   +1 more source

Malignancies and immunoglobulin G4‐related disease

Rheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source

Classic Hodgkin lymphoma transformation into composite lymphoma complicated with Guillain‒Barré syndrome after chemotherapy: A case report

Current Problems in Cancer: Case Reports
Classic Hodgkin lymphoma rarely undergoes pathological transformation, and the transformation type is usually common non-Hodgkin lymphoma. This study describes a 71-year-old male diagnosed with stage III classic Hodgkin lymphoma positive for Epstein‒Barr
Li He, Ying Bao
doaj  

The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease [PDF]

, 2001
Alaa A. Kandil, Shouki Bazarbashi, Walid A. Mourad   +2 more
openalex   +1 more source

Development of a prognostic nomogram and genetic insights for prostate cancer patients with secondary primary malignancies: A SEER retrospective cohort study and Mendelian randomization analysis

UroPrecision, EarlyView.
Abstract Background Prostate cancer (PCa) patients are at risk of developing second primary malignancies (SPMs), which can significantly shorten their survival. Understanding the risk of SPMs and associated factors is crucial to the optimization of patient follow‐up.
Qi Zhang, Lufan Liang, Ziyu Liu, Ziyang Yang, Jiahao Cheng, Xuan Li, Yueting Huang, Weisi Chen, Jiazhen Yin, Ligong Chen, Zhang Cao, Di Gu   +11 more
wiley   +1 more source

Lymphoma resembling hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient

, 1993
Michael A. Nalesnik, Parmjeet Randhawa, Anthony J. Demetris, Joseph Locker, A Casavilla, John J. Fung   +5 more
openalex   +1 more source